Genmab — November 2016
-
Den voksende kassebeholdning
er en stærk buffer den dag Genmab eventuelt står med solide data i relation til solide tumorer. -
Rigtigt Solsen.Kassebeholdningen passerer så min. 10 milliarder kr.
-
For min skyld kan de købe dametasker bare de ikke taber penge på at lade dem stå. CFO tjener rigeligt med penge og det er hans opgave at sørge for at der ikke tabes penge, det bliver han målt på, men mangler svar på hvad deres strategi er i forhold til den likvide beholdning
-
Det har vi spurgt om ved stort set hver eneste Q&A.

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind